Treatment considerations for patients with pemphigus during the COVID-19 pandemic.
作者信息
Shakshouk Hadir, Daneshpazhooh Maryam, Murrell Dedee F, Lehman Julia S
机构信息
Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Dermatology, Andrology and Venereology, Alexandria University, Alexandria, Egypt.
Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
J Am Acad Dermatol. 2020 Jun;82(6):e235-e236. doi: 10.1016/j.jaad.2020.04.005. Epub 2020 Apr 10.
Abstract
摘要
相似文献
1
Treatment considerations for patients with pemphigus during the COVID-19 pandemic.COVID-19大流行期间天疱疮患者的治疗考量
J Am Acad Dermatol. 2020 Jun;82(6):e235-e236. doi: 10.1016/j.jaad.2020.04.005. Epub 2020 Apr 10.
2
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.首例多发性骨髓瘤合并 COVID-19 患者经托珠单抗治疗后成功缓解。
Blood Adv. 2020 Apr 14;4(7):1307-1310. doi: 10.1182/bloodadvances.2020001907.
3
Tocilizumab administration in a refractory case of COVID-19.托珠单抗在一例难治性新型冠状病毒肺炎病例中的应用
Int J Antimicrob Agents. 2020 Aug;56(2):106043. doi: 10.1016/j.ijantimicag.2020.106043. Epub 2020 Jun 2.
4
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.一名镰状细胞病患者出现快速进展且严重的新冠病毒肺炎并伴有严重急性胸部综合征，使用托珠单抗成功治疗。
Am J Hematol. 2020 Jul;95(7):876-878. doi: 10.1002/ajh.25833. Epub 2020 May 12.
5
May IL-17 have a role in COVID-19 infection?白细胞介素-17在新型冠状病毒肺炎感染中起作用吗？
Med Hypotheses. 2020 Jul;140:109749. doi: 10.1016/j.mehy.2020.109749. Epub 2020 Apr 22.
6
Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab.与白细胞介素-6升高相关的血管微血栓形成。在接受托珠单抗治疗的COVID-19患者中出现的严重急性呼吸窘迫综合征。
Adv Respir Med. 2020;88(5):468-469. doi: 10.5603/ARM.a2020.0123.
7
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.托珠单抗，一种抗白细胞介素-6受体抗体，用于治疗新型冠状病毒肺炎相关呼吸衰竭：一例病例报告。
Ann Oncol. 2020 Jul;31(7):961-964. doi: 10.1016/j.annonc.2020.03.300. Epub 2020 Apr 2.
8
Early tocilizumab treatment could improve survival among COVID-19 patients.早期使用托珠单抗治疗可提高新冠病毒疾病患者的生存率。
Clin Exp Rheumatol. 2020 May-Jun;38(3):578. Epub 2020 May 27.
9
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.托珠单抗联合糖皮质激素治疗重症和危重症 COVID-19 患者：单中心经验
Med Clin (Barc). 2020 Nov 13;155(9):410-411. doi: 10.1016/j.medcli.2020.07.001. Epub 2020 Jul 9.
10
COVID-19 in hem/onc news.血液肿瘤新闻中的新冠病毒肺炎
Clin Adv Hematol Oncol. 2020 May;18(5):248.
引用本文的文献
1
Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study.大疱性类天疱疮患者感染新型冠状病毒肺炎的结局及危险因素：一项横断面研究
Front Immunol. 2025 Apr 25;16:1568801. doi: 10.3389/fimmu.2025.1568801. eCollection 2025.
2
Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases.利妥昔单抗治疗天疱疮患者出现意外治疗反应的联合治疗：五例报告
Clin Case Rep. 2023 Nov 25;11(11):e8208. doi: 10.1002/ccr3.8208. eCollection 2023 Nov.
3
The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases.新冠疫情初期对自身免疫性大疱性疾病患者的影响
Cureus. 2023 Sep 19;15(9):e45545. doi: 10.7759/cureus.45545. eCollection 2023 Sep.
4
Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia.在2019冠状病毒病大流行期间使用免疫抑制疗法治疗天疱疮的考量，重点关注利妥昔单抗：来自澳大利亚单一中心经验的病例报告
Front Med (Lausanne). 2023 Mar 14;10:1149742. doi: 10.3389/fmed.2023.1149742. eCollection 2023.
5
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?严重急性呼吸综合征冠状病毒2疫苗接种后自身免疫性大疱性疾病的加重：是否存在关联？
Front Med (Lausanne). 2022 Jul 19;9:957169. doi: 10.3389/fmed.2022.957169. eCollection 2022.
6
Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.自身免疫性大疱性疾病患者 COVID-19 的不良结局和严重程度：一项历史性队列研究。
Dermatol Ther. 2022 Sep;35(9):e15672. doi: 10.1111/dth.15672. Epub 2022 Jul 21.
7
Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the Clinician.大疱性疾病患者生活质量的改善：原发性文献综述及临床医生的考量
Clin Cosmet Investig Dermatol. 2022 Jan 10;15:27-42. doi: 10.2147/CCID.S324331. eCollection 2022.
8
Epidemiology of Pemphigus.天疱疮的流行病学
JID Innov. 2021 Feb 20;1(1):100004. doi: 10.1016/j.xjidi.2021.100004. eCollection 2021 Mar.
9
Pemphigus-The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic.天疱疮——新冠疫情期间临床、研究与治疗的关键
Biomedicines. 2021 Oct 28;9(11):1555. doi: 10.3390/biomedicines9111555.
10
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus.COVID 疫苗接种在接受利妥昔单抗治疗的患者中：来自伊朗的两例病例报告及当前知识的综述，特别关注天疱疮。
Dermatol Ther. 2022 Jan;35(1):e15216. doi: 10.1111/dth.15216. Epub 2021 Dec 1.
本文引用的文献
1
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.大剂量静脉注射免疫球蛋白作为新型冠状病毒肺炎病情恶化患者的一种治疗选择
Open Forum Infect Dis. 2020 Mar 21;7(3):ofaa102. doi: 10.1093/ofid/ofaa102. eCollection 2020 Mar.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.一线利妥昔单抗联合短期泼尼松与单独泼尼松治疗天疱疮（Ritux 3）：一项前瞻性、多中心、平行组、开放标签随机试验。
Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.
4
Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.老年天疱疮：临床表现、治疗及预后
J Am Geriatr Soc. 2012 Jun;60(6):1185-7. doi: 10.1111/j.1532-5415.2012.03987.x.
5
A randomized double-blind trial of intravenous immunoglobulin for pemphigus.静脉注射免疫球蛋白治疗天疱疮的随机双盲试验。
J Am Acad Dermatol. 2009 Apr;60(4):595-603. doi: 10.1016/j.jaad.2008.09.052.
Zotero 插件